Hadas Dvory-Sobol Selected Research

sofosbuvir velpatasvir voxilaprevir drug combination

1/2019	Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received a Sofosbuvir/Velpatasvir-containing regimen: Results from a retreatment study.
1/2018	Deferred treatment with sofosbuvir-velpatasvir-voxilaprevir for patients with chronic hepatitis C virus who were previously treated with an NS5A inhibitor: an open-label substudy of POLARIS-1.
1/2017	Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection.
1/2017	Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials.
1/2017	Sofosbuvir-velpatasvir-voxilaprevir with or without ribavirin in direct-acting antiviral-experienced patients with genotype 1 hepatitis C virus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hadas Dvory-Sobol Research Topics

Disease

36	Infections 12/2022 - 11/2006
19	Fibrosis (Cirrhosis) 10/2020 - 06/2013
10	Chronic Hepatitis C 10/2020 - 01/2016
6	Hepatitis C 01/2021 - 11/2010
5	Neoplasms (Cancer) 10/2007 - 01/2004
4	Liver Diseases (Liver Disease) 01/2019 - 11/2014
3	Colonic Neoplasms (Colon Cancer) 01/2008 - 07/2003
3	Carcinogenesis 10/2007 - 07/2003
3	Colorectal Neoplasms (Colorectal Cancer) 11/2006 - 09/2005
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 10/2019
2	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 11/2006
2	Headache (Headaches) 01/2018 - 01/2017
2	Diarrhea 01/2017 - 01/2017
2	Nausea 01/2017 - 01/2017
2	Fatigue 01/2017 - 01/2017
2	Hepatitis 06/2016 - 09/2015
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2007 - 11/2006
2	Stomach Neoplasms (Stomach Cancer) 01/2007 - 11/2006
1	Hemorrhage 01/2019
1	Sepsis (Septicemia) 01/2019
1	Esophageal and Gastric Varices (Esophageal Varices) 01/2019
1	Virus Diseases (Viral Diseases) 01/2019
1	Nasopharyngitis 01/2018
1	Septic Shock (Toxic Shock Syndrome) 05/2017
1	Syncope (Fainting) 01/2017
1	Pulmonary Embolism 01/2017
1	Anemia 01/2017
1	Coinfection 01/2017
1	Gastroenteritis 01/2017
1	HIV Infections (HIV Infection) 01/2017
1	Bronchitis 01/2017
1	Neutropenia 06/2013
1	Rupture 12/2009
1	Prostatic Neoplasms (Prostate Cancer) 10/2007
1	Neoplasm Metastasis (Metastasis) 01/2006

Drug/Important Bio-Agent (IBA)

27	SofosbuvirIBA 10/2019 - 06/2013
18	Ribavirin (Virazole)FDA LinkGeneric 01/2019 - 06/2013
13	sofosbuvir drug combination ledipasvirIBA 01/2021 - 09/2015
12	velpatasvirIBA 10/2019 - 12/2015
8	Antiviral Agents (Antivirals)IBA 10/2019 - 11/2010
8	NucleotidesIBA 01/2018 - 12/2014
8	ledipasvirIBA 01/2017 - 04/2014
5	sofosbuvir velpatasvir voxilaprevir drug combinationIBA 01/2019 - 01/2017
5	InterferonsIBA 01/2017 - 04/2014
4	TabletsIBA 01/2019 - 04/2014
4	voxilaprevirIBA 01/2017 - 11/2016
3	Protease Inhibitors (Protease Inhibitor)IBA 01/2017 - 01/2016
3	beta CateninIBA 10/2007 - 11/2006
3	TCF Transcription FactorsIBA 10/2007 - 11/2006
2	RNA (Ribonucleic Acid)IBA 12/2022 - 05/2017
2	Proteins (Proteins, Gene)FDA Link 10/2020 - 01/2017
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2006 - 09/2005
2	Celecoxib (Celebrex)FDA Link 09/2005 - 01/2004
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2019
1	CreatinineIBA 01/2017
1	Cytidine Triphosphate (CTP)IBA 06/2016
1	GS-9451IBA 01/2016
1	GS-9669IBA 01/2016
1	Peptide Hydrolases (Proteases)FDA Link 12/2015
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2015
1	Interferon-alpha (Interferon Alfa)IBA 01/2015
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 12/2014
1	Pharmaceutical PreparationsIBA 06/2013
1	peginterferon alfa-2a (Pegasys)FDA Link 06/2013
1	Peptides (Polypeptides)IBA 12/2009
1	bcl-2 Homologous Antagonist-Killer Protein (bcl 2 Homologous Antagonist Killer Protein)IBA 01/2008
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2006
1	3- (3,4- difluorophenyl)- 4- (4- (methylsulfonyl)phenyl)- 2(5H)- furanoneIBA 01/2006
1	Sulindac (Copal)FDA LinkGeneric 01/2006
1	CurcuminIBA 09/2005
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2005
1	Cyclin D1IBA 07/2003

Therapy/Procedure

14	Therapeutics 10/2020 - 01/2006
4	Liver Transplantation 05/2017 - 01/2015
3	Transplantation 05/2017 - 01/2015
3	Duration of Therapy 01/2017 - 01/2016
2	Retreatment 01/2019 - 10/2017
1	Off-Label Use 10/2019
1	Renal Dialysis (Hemodialysis) 10/2019
1	Peritoneal Dialysis 10/2019